Page last updated: 2024-08-24

ranolazine and Cancer of Intestines

ranolazine has been researched along with Cancer of Intestines in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Castellino, FJ; Gutierrez, LS; Navari, RM; Paoni, NF; Pollard, M; Risatti, CA; Suckow, MA; Taylor, RE; Wolter, WR	1

Other Studies

1 other study(ies) available for ranolazine and Cancer of Intestines

Article	Year
The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice. Cancer letters, 2004, Jun-25, Volume: 209, Issue:2 Topics: Acetanilides; Adenomatous Polyposis Coli; Alleles; Animals; Carcinogens; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Genes, APC; Injections, Intraperitoneal; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Invasiveness; Piperazines; Ranolazine	2004

Article

Year

The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice.

Cancer letters, 2004, Jun-25, Volume: 209, Issue:2

Topics: Acetanilides; Adenomatous Polyposis Coli; Alleles; Animals; Carcinogens; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Genes, APC; Injections, Intraperitoneal; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Invasiveness; Piperazines; Ranolazine

2004